Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Revenue: 2022-2025

Historic Revenue for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $13.3 million.

  • Gossamer Bio's Revenue rose 40.23% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year decrease of 79.74%. This contributed to the annual value of $90.7 million for FY2024, which is 771.30% up from last year.
  • Per Gossamer Bio's latest filing, its Revenue stood at $13.3 million for Q3 2025, which was up 15.71% from $11.5 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Revenue ranged from a high of $95.8 million in Q2 2024 and a low of -$14.6 million during Q4 2024.
  • In the last 3 years, Gossamer Bio's Revenue had a median value of -$3.1 million in 2024 and averaged $9.9 million.
  • Examining YoY changes over the last 5 years, Gossamer Bio's Revenue showed a top increase of 2,895.04% in 2024 and a maximum decrease of 351.44% in 2024.
  • Gossamer Bio's Revenue (Quarterly) stood at -$3.5 million in 2022, then rose by 6.31% to -$3.2 million in 2023, then tumbled by 351.44% to -$14.6 million in 2024, then surged by 40.23% to $13.3 million in 2025.
  • Its Revenue was $13.3 million in Q3 2025, compared to $11.5 million in Q2 2025 and $9.9 million in Q1 2025.